Latest VR Adviser, LLC Stock Portfolio
$3.30Billion | No. of Holdings #33
VR Adviser, LLC Performance
2026 Q2+34.04%
YTD+63.56%
2025+58.45%
About VR Adviser, LLC and 13F Hedge Fund Stock Holdings
Venrock Adviser, LLC is a hedge fund based in New York, NY. On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Venrock Adviser, LLC reported an equity portfolio of $3.3 Billions as of 30 Jun, 2026. <br><br> The top stock holdings of Venrock Adviser, LLC are , , ERAS. The fund has invested 34.2% of it's portfolio in APOGEE THERAPEUTICS INC and 12% of portfolio in ORUKA THERAPEUTICS INC. <br><br> The fund managers got completely rid off KALVISTA PHARMACEUTICALS INC (KALV), ENGENE HOLDINGS INC and TENAX THERAPEUTICS INC (TENX) stocks. They significantly reduced their stock positions in ENLIVEN THERAPEUTICS INC, CYTOMX THERAPEUTICS INC (CTMX) and SPYRE THERAPEUTICS INC (AGLE). Venrock Adviser, LLC opened new stock positions in ACHIEVE LIFE SCIENCE INC (ACHV), PARABILIS MEDICINES INC and INMED PHARMACEUTICALS INC (INM). The fund showed a lot of confidence in some stocks as they added substantially to X4 PHARMACEUTICALS INC (XFOR), RELMADA THERAPEUTICS INC (RLMD) and ARTIVA BIOTHERAPEUTICS INC.
VR Adviser, LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$3.30Billion
as of Aug 14, 2026VR Adviser, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Venrock Adviser, LLC made a return of 34.04% in the last quarter. In trailing 12 months, it's portfolio return was 203.25%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| achieve life science inc | 17,964,200 |
| parabilis medicines inc | 17,106,200 |
| research alliance corp iii | 3,210,000 |
| inmed pharmaceuticals inc | 50,662 |
New stocks bought by VR Adviser, LLC
Additions
| Ticker | % Inc. |
|---|---|
| x4 pharmaceuticals inc | 485 |
| relmada therapeutics inc | 41.31 |
| artiva biotherapeutics inc | 26.97 |
| erasca inc | 9.21 |
| savara inc | 7.32 |
Additions to existing portfolio by VR Adviser, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| enliven therapeutics inc | -69.51 |
| cytomx therapeutics inc | -50.09 |
| spyre therapeutics inc | -18.99 |
| cogent biosciences inc | -17.89 |
| viridian therapeutics inc | -16.09 |
VR Adviser, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| kalvista pharmaceuticals inc | -130,331,000 |
| engene holdings inc | -32,493,300 |
| tenax therapeutics inc | -26,787,400 |
| septerna inc | -12,160,500 |
VR Adviser, LLC got rid off the above stocks
Sector Distribution
Venrock Adviser, LLC has about 58.1% of it's holdings in Others sector.
- Others
- Healthcare
| Sector | % |
|---|---|
| Others | 58.1 |
| Healthcare | 41.9 |
Market Cap. Distribution
Venrock Adviser, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- UNALLOCATED
- MID-CAP
- SMALL-CAP
| Category | % |
|---|---|
| UNALLOCATED | 58.1 |
| MID-CAP | 23.2 |
| SMALL-CAP | 18.2 |
Stocks belong to which Index?
About 27.9% of the stocks held by Venrock Adviser, LLC either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 72.1 |
| RUSSELL 2000 | 27.9 |
VR Adviser, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of VR Adviser, LLC
Venrock Adviser, LLC has 33 stocks in it's portfolio. About 80.4% of the portfolio is in top 10 stocks. ORIC proved to be the most loss making stock for the portfolio. was the most profitable stock for Venrock Adviser, LLC last quarter.
$3.30BTotal Value
37.00Positions
14 Aug, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Achieve Life Science Inc VR Adviser, LLC's holding in Achieve Life Science Inc over time | 0.54% | 2,751,030 | $17.96M 0.54% | Newnew position | |
 Spyre Therapeutics Inc VR Adviser, LLC's holding in Spyre Therapeutics Inc over time | 8.04% | 2,985,450 | $265.05M 8.04% | 18.99%decreased 18.99 percentreduced | |
 Jade Biosciences Inc VR Adviser, LLC's holding in Jade Biosciences Inc over time | 2.17% | 3,220,360 | $71.56M 2.17% | 0%unchanged 0 percentunchanged | |
 Cullinan Therapeutics Inc VR Adviser, LLC's holding in Cullinan Therapeutics Inc over time | 0.76% | 1,379,960 | $25.13M 0.76% | 0%unchanged 0 percentunchanged | |
 Cogent Biosciences Inc VR Adviser, LLC's holding in Cogent Biosciences Inc over time | 1.93% | 1,642,170 | $63.55M 1.93% | 17.89%decreased 17.89 percentreduced | |
 Cytomx Therapeutics Inc VR Adviser, LLC's holding in Cytomx Therapeutics Inc over time | 0.57% | 4,982,120 | $18.68M 0.57% | 50.09%decreased 50.09 percentreduced | |
 CYBN Cybin IncCybin IncCYBN | 0.77% | 3,851,650 | $25.46M 0.77% | 0%unchanged 0 percentunchanged | |
 Dyne Therapeutics Inc VR Adviser, LLC's holding in Dyne Therapeutics Inc over time | 1.46% | 2,173,910 | $48.28M 1.46% | 0%unchanged 0 percentunchanged | |
 Erasca Inc Erasca IncERAS VR Adviser, LLC's holding in Erasca Inc over time | 9.94% | 17,891,800 | $327.78M 9.94% | 9.21%increased 9.21 percentadded | |
 Damora Therapeutics Inc VR Adviser, LLC's holding in Damora Therapeutics Inc over time | 2.84% | 3,603,600 | $93.73M 2.84% | 0%unchanged 0 percentunchanged | |
 Inmed Pharmaceuticals Inc VR Adviser, LLC's holding in Inmed Pharmaceuticals Inc over time | 0% | 32,685 | $50.7K 0% | Newnew position | |
 Century Therapeutics Inc VR Adviser, LLC's holding in Century Therapeutics Inc over time | 0.65% | 8,695,650 | $21.30M 0.65% | 0%unchanged 0 percentunchanged | |
 Kalvista Pharmaceuticals Inc VR Adviser, LLC's holding in Kalvista Pharmaceuticals Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Ocular Therapeutix Inc VR Adviser, LLC's holding in Ocular Therapeutix Inc over time | 3.08% | 10,346,900 | $101.61M 3.08% | 0%unchanged 0 percentunchanged | |
 Oric Pharmaceuticals Inc VR Adviser, LLC's holding in Oric Pharmaceuticals Inc over time | 1.42% | 4,319,760 | $46.78M 1.42% | 0%unchanged 0 percentunchanged | |
 Relmada Therapeutics Inc VR Adviser, LLC's holding in Relmada Therapeutics Inc over time | 1.44% | 6,844,300 | $47.36M 1.44% | 41.31%increased 41.31 percentadded | |
 Surrozen Inc Surrozen IncSRZN VR Adviser, LLC's holding in Surrozen Inc over time | 0.5% | 632,931 | $16.42M 0.5% | 0%unchanged 0 percentunchanged | |
 Savara Inc Savara IncSVRA VR Adviser, LLC's holding in Savara Inc over time | 2.75% | 14,745,900 | $90.83M 2.75% | 7.32%increased 7.32 percentadded | |
 Tenax Therapeutics Inc VR Adviser, LLC's holding in Tenax Therapeutics Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Vor Biopharma Inc VR Adviser, LLC's holding in Vor Biopharma Inc over time | 1.7% | 3,041,720 | $56.00M 1.7% | 0%unchanged 0 percentunchanged | |